| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gabapentin | adenosine receptor a1 | small molecule | NA | drugbank | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | approved,investigational | agonist |
| gabapentin | voltage-dependent n-type calcium channel | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.45 | approved,investigational | inhibitor |
| gabapentin | voltage-dependent n-type calcium channel | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.45 | approved,investigational | inhibitor,modulator |
| gabapentin | voltage-dependent calcium channel subunit alpha-2/delta-1 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.06 | approved,investigational | inhibitor |
| gabapentin | voltage-dependent calcium channel subunit alpha-2/delta-1 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.06 | approved,investigational | inhibitor,modulator |
| gabapentin | voltage-dependent calcium channel subunit alpha-2/delta-2 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.7 | approved,investigational | inhibitor,modulator |
| gabapentin | voltage-dependent calcium channel subunit alpha-2/delta-2 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
1.7 | approved,investigational | inhibitor |
| gabapentin | potassium voltage-gated channel subfamily kqt member 3 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.47 | approved,investigational | activator |
| gabapentin | potassium voltage-gated channel subfamily kqt member 5 | small molecule | NA | drugbank , DGIDB | Generalization (Psychology)[MeSHID:D005793] Postherpetic neuralgia[MeSHID:D051474] Neoplasm Metastasis[MeSHID:D009362] Peripheral Neuropathy[MeSHID:D010523] Pain[MeSHID:D010146] Diabetic Neuralgia[MeSHID:D003929] Seizures Focal[MeSHID:D012640] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
0.42 | approved,investigational | activator |
| click here to return to the previous page | ||||||||